Second Forward View Examination of Proximal Colon on Adenoma Detection Rate
Impact of Second Forward View Examination of Proximal Colon on Adenoma Detection Rate: A Randomized Clinical Trial
1 other identifier
interventional
392
1 country
1
Brief Summary
This clinical trial is being conducted to assess whether second forward view examination of proximal colon could increase adenoma detection rate of right colon.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 2, 2018
CompletedFirst Posted
Study publicly available on registry
August 7, 2018
CompletedStudy Start
First participant enrolled
September 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2019
CompletedJuly 12, 2019
July 1, 2019
9 months
August 2, 2018
July 11, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
per-patient detection rate of adenoma of proximal colon
the number of patients with at least one adenoma identified divided by total number of patients completing colonoscopy
1 day
Study Arms (2)
Second Examination
EXPERIMENTALEligible patients who consent to participate undergo planned colonoscopy by endoscopists performing procedures that day per normal standard of care. The colonoscope is passed to the cecum and then withdrawn to the hepatic flexure with washing and aspirating of colonic contents as needed to optimize visualization of colonic mucosa. Then, the colonoscope is inserted to the cecum and withdrawn to the hepatic flexure again for second examination.
Traditional Examinaiton
NO INTERVENTIONEligible patients who consent to participate undergo planned colonoscopy by endoscopists performing procedures that day per normal standard of care. The colonoscope is passed to the cecum and then withdrawn to the hepatic flexure with washing and aspirating of colonic contents as needed to optimize visualization of colonic mucosa. Then, the colonoscope is withdrawn to the anus directly.
Interventions
The colonoscopy is passed to the cecum and then withdrawn to hepatic flexure. Then, the scopy is inserted to the cecum and withdrawn to hepatic flexure again for second foreard view examination.
Eligibility Criteria
You may qualify if:
- all patients undergoing colonoscopy for screening in our hospital
You may not qualify if:
- previous history of resection of colon;
- familial polyposis syndrome
- inflammatory bowel disease
- active antiplatelet or anticoagulant therapy prevent polypectomy;
- pregnancy or lactating women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ningbo NO.1 hospital
Ningbo, Zhejiang, 315010, China
Related Publications (1)
Shan K, Lu H, Zhang Z, Xie J, Xu L, Wang W, Hu C, Xu L. Impact of second forward-view examination on adenoma detection rate during unsedated colonoscopy: a randomized controlled trial. BMC Gastroenterol. 2021 May 10;21(1):213. doi: 10.1186/s12876-021-01783-9.
PMID: 33971824DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 2, 2018
First Posted
August 7, 2018
Study Start
September 1, 2018
Primary Completion
May 31, 2019
Study Completion
June 30, 2019
Last Updated
July 12, 2019
Record last verified: 2019-07